Advertisement
Australia markets closed
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • AUD/USD

    0.6613
    -0.0008 (-0.12%)
     
  • OIL

    79.67
    +0.41 (+0.52%)
     
  • GOLD

    2,378.40
    +38.10 (+1.63%)
     
  • Bitcoin AUD

    95,302.87
    +2,960.05 (+3.21%)
     
  • CMC Crypto 200

    1,303.27
    -54.74 (-4.03%)
     
  • AUD/EUR

    0.6130
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0984
    +0.0015 (+0.14%)
     
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NASDAQ

    18,113.46
    +28.46 (+0.16%)
     
  • FTSE

    8,444.03
    +62.68 (+0.75%)
     
  • Dow Jones

    39,387.76
    +331.36 (+0.85%)
     
  • DAX

    18,829.53
    +142.93 (+0.76%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

Redcare Pharmacy Reports First Quarter 2024 Earnings

Redcare Pharmacy (ETR:RDC) First Quarter 2024 Results

Key Financial Results

  • Revenue: €560.2m (up 51% from 1Q 2023).

  • Net loss: €7.81m (loss narrowed by 24% from 1Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Redcare Pharmacy Earnings Insights

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Consumer Retailing industry in Europe.

Performance of the market in Germany.

The company's shares are down 3.6% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Redcare Pharmacy.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.